aTyr Pharma(US:LIFE) Newsfile·2025-10-07 22:04Core Viewpoint - Allied Critical Metals Inc. has increased its non-brokered private placement offering to raise gross proceeds of up to $16,250,000 by issuing up to 27,083,333 common shares at a price of $0.60 per share due to strong investor demand [1]. Group 1: Offering Details - The shares will be offered under the Listed Issuer Financing Exemption, allowing sales to purchasers in Canada (excluding Quebec) and certain jurisdictions outside Canada, without a hold period under Canadian securities laws [2]. - The offering is subject to approval from the Canadian Securities Exchange (CSE) and is expected to close around October 21, 2025 [4][5]. - The company may pay finder's fees of up to 7% of the gross proceeds in cash and issue finders warrants equal to up to 7% of the shares issued, exercisable for 24 months at $0.60 per share [5]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for ongoing exploration and development activities on the Borralha Tungsten Project and Vila Verde Tungsten Project, as well as for additional working capital [4]. Group 3: Company Overview - Allied Critical Metals Inc. is focused on the expansion and revitalization of its 100% owned Borralha and Vila Verde Tungsten Projects in northern Portugal, with tungsten being designated a critical metal by the U.S. and other western countries [7]. - The tungsten market is valued at approximately USD $5 to $6 billion and is utilized in various industries, including defense, automotive, manufacturing, electronics, and energy [7].